<DOC>
	<DOCNO>NCT01903798</DOCNO>
	<brief_summary>This clinical trial test two new therapy treatment alcoholic hepatitis . Patients `` respond '' current standard care therapy alcoholic hepatitis ( corticosteroid/prednisolone therapy ) 1 week treatment randomly assign either continue standard therapy , , begin treatment rilonacept combination standard therapy . Patients `` non-responders '' current standard care therapy 1 week treatment randomly assign standard care begin treatment mycophenolate mofetil combination standard therapy . Patients treat total 4 week clinical trial . Patients follow five month complete therapy ( 6 month total ) .</brief_summary>
	<brief_title>A Safety Efficacy Study Mycophenolate Mofetil Rilonacept Patients With Alcoholic Hepatitis</brief_title>
	<detailed_description>This prospective , randomized trial two experimental treatment , prednisolone + mycophenolate mofetil prednisolone + rilonacept , comparison standard care , patient alcoholic hepatitis . Patients start therapy prednisolone . At Day 8 response prednisolone determine use Lille score . Patients Lille score â‰¥ 0.45 randomized standard care ( continue prednisolone , stop therapy and/or offer palliative care ) prednisolone continue mycophenolate add next three week . Patients Lille score &lt; 0.45 randomize continue prednisolone alone ( standard care ) rilonacept add treatment regimen ( experimental group ) next three week . Patients complete follow-up visit Week 12 Week 24 .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Alcoholic</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>History chronic alcohol consumption ( define &gt; 60g ethanol/day woman &gt; 80g ethanol/day men ) least past 5 year Less 8 week last intake alcohol Screening Maddrey 's Discriminant Function score ( DF ) &gt; 32 Willing undergo liver biopsy histological assessment alcoholic hepatitis . Willing provide liver tissue , whole blood , stool ascitic fluid part correlative study Onset jaundice &lt; 3 month prior Screening Age great equal 18 year Exclusion Criteria ( Brief ) : Liver disease significantly cause etiology alcohol . Upper GI bleed require transfusion within 48 hour prior start prednisolone ( Day 1 ) Infection treat appropriate antibiotic le 72 hour respond appropriately 72 hour antibiotic treatment prior start prednisolone ( Day 1 ) Clinical evidence select active infection past 3 month ( fungal , mycobacterial , cytomegalovirus ( CMV ) , herpes , coccidioidomycosis , tuberculosis ( TB ) human immunodeficiency virus ( HIV ) ) Renal insufficiency Laboratory exclusion Hemoglobin &lt; 7g/dL Total Bilirubin &lt; 7.5mg/dL Aspartate aminotransferase ( AST ) &gt; 500 IU/mL ; AST : Alanine aminotransferase ( ALT ) ratio &lt; 1 Pregnant breastfeed unwilling use appropriate birth control Other clinically significant disease ( uncontrolled diabetes , severe cardiovascular pulmonary disease , transplant recipient , recent cancer ) Use oral systemic corticosteroid 7 day 14 day prior Day 1 likely use oral systemic corticosteroid first 12 week clinical trial underlie disease Use select contraindicate medication Previous randomization trial Based investigator judgment , subject capable complying study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>